Announcement on the Suspension of Trading Due to Planned Change of Company Control

Amoy Diagnostics Co., Ltd.·May 31, 2026·2 pages

✨ AI Summary

Xiamen Ade Biological Technology Co., Ltd. announces a suspension of trading for its shares due to its controlling shareholder, Forward Investment (Hong Kong) Limited, planning a change of control. The suspension will begin on June 1, 2026, and is expected to last no more than two trading days. Investors are advised to be aware of the associated risks.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Xiamen Ade Biological Technology Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, without any false records, misleading statements, or significant omissions.

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.